Press release
Companion Diagnostics in Oncology Market to Reach USD 16.2 Billion by 2034
Companion Diagnostics in Oncology
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/50046
Key Takeaways
• Market Size (2024): USD 8.9 billion
• Forecast (2034): USD 16.2 billion
• CAGR (2025-2034): 6.2 %
• Leading Companies: F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., QIAGEN N.V., Agilent Technologies Inc., Abbott Laboratories, Illumina Inc., Myriad Genetics Inc., Bio-Rad Laboratories Inc., Guardant Health Inc., and Siemens Healthineers AG.
• Core Applications: Breast Cancer (HER2, BRCA) | Lung Cancer (EGFR, ALK, ROS1) | Colorectal Cancer (KRAS, NRAS) | Melanoma (BRAF) | Prostate and Ovarian Cancers.
Market Story
Companion diagnostics are redefining oncology by linking diagnostic precision with therapeutic efficacy. These tests identify genetic mutations or protein expressions to match patients with targeted drugs-transforming cancer from a generic disease treatment model to a personalized, molecular-driven one.
The rapid integration of next-generation sequencing (NGS) and liquid biopsy technologies has enabled faster, minimally invasive testing. Meanwhile, partnerships between diagnostic developers and pharma giants are accelerating the co-development of CDx assays alongside novel cancer drugs, ensuring simultaneous regulatory approvals.
Market Segmentation
• By Technology: Polymerase Chain Reaction (PCR) | Immunohistochemistry (IHC) | Next-Generation Sequencing (NGS) | In Situ Hybridization (ISH) | Others (Microarray, Flow Cytometry)
• By Indication: Lung Cancer | Breast Cancer | Colorectal Cancer | Melanoma | Prostate Cancer | Others
• By End User: Hospitals & Reference Labs | Pharmaceutical & Biotech Companies | Academic Research Institutes
• By Region:
o North America: Largest market; strong regulatory support from FDA for simultaneous drug-diagnostic approvals.
o Europe: Growing biomarker research and adoption of NGS-based companion tests.
o Asia Pacific: Fastest-growing region; rising cancer prevalence and government genomics initiatives in China and Japan.
o Latin America & MEA: Increasing partnerships for diagnostic infrastructure development.
Explore Full Report here: https://exactitudeconsultancy.com/reports/50046/companion-diagnostics-oncology-market
Recent Developments
• 2025: Roche launched a new NGS-based CDx panel for multi-tumor genomic profiling.
• 2024: Thermo Fisher Scientific introduced an integrated platform combining molecular testing with AI-assisted oncology analytics.
• 2023: QIAGEN partnered with AstraZeneca for co-development of EGFR mutation testing for lung cancer therapy.
• 2022: Guardant Health expanded its liquid biopsy portfolio with FDA clearance for tumor-agnostic applications.
Expert Quote
"Precision oncology depends on diagnostics that deliver certainty at the molecular level. As biomarker-guided therapies multiply, companion diagnostics are becoming the bridge between innovation and individualized patient outcomes," said Irfan Tamboli, Business Development Executive at Exactitude Consultancy.
Get Your Exclusive Offer with up to 10% Discount : https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=50046
Market Drivers
1. Rising Prevalence of Cancer and Demand for Personalized Therapies.
2. Advances in NGS and Liquid Biopsy Technologies.
3. Regulatory Support for Drug-Diagnostic Co-Development.
4. Increasing Pharma-Diagnostic Collaborations for Targeted Drug Launches.
Forecast Outlook
Between 2025 and 2034, the market will witness large-scale adoption of AI-driven biomarker interpretation, multiplex CDx panels, and cloud-based diagnostic-drug data integration. Precision medicine networks in Asia and North America are expected to fuel global demand.
Conclusion
The Companion Diagnostics in Oncology Market stands at the center of the precision-medicine revolution. As genetic profiling becomes standard care, CDx solutions will continue to guide oncologists toward the right drug, at the right dose, for the right patient.
This report is also available in the following languages : Japanese (コンパニオン診断腫瘍学市場), Korean (동반 진단 종양학 시장), Chinese (伴随诊断肿瘤市场), French (Marché des tests compagnons en oncologie), German (Markt für Begleitdiagnostik in der Onkologie), and Italian (Mercato oncologico della diagnostica di accompagnamento), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @ https://exactitudeconsultancy.com/reports/50046/companion-diagnostics-oncology-market#request-a-sample
Related Reports
Companion Animal Health Market
https://exactitudeconsultancy.com/reports/72382/companion-animal-health-market
Veterinary Vaccines Market
https://exactitudeconsultancy.com/reports/72412/veterinary-vaccines-market
Companion Diagnostics (CDx) Development Market
https://exactitudeconsultancy.com/reports/73474/companion-diagnostics-cdx-development-market
Multifunctional Household Robot Market
https://exactitudeconsultancy.com/reports/75205/multifunctional-household-robot-market
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
https://exactitudeconsultancy.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Companion Diagnostics in Oncology Market to Reach USD 16.2 Billion by 2034 here
News-ID: 4266778 • Views: …
More Releases from Exactitude Consultancy
Cold Planer Market Sees Consistent Growth Supported by Global Road Rehabilitatio …
The global cold planer market is experiencing steady growth as governments and private contractors increase spending on road rehabilitation, resurfacing, and infrastructure modernization. Cold planers, also known as milling machines, are widely used to remove damaged asphalt and concrete surfaces efficiently, supporting sustainable road construction practices.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/68250
Key Market Highlights
• Increasing focus on road maintenance and resurfacing projects
• Growing demand for efficient and precision milling…
Credit Management Software Market Accelerates as Organizations Focus on Risk Mit …
The global credit management software market is witnessing robust growth as organizations across industries adopt digital solutions to manage credit risk, improve receivables performance, and strengthen financial controls. Credit management software enables businesses to automate credit scoring, monitor customer creditworthiness, and streamline collections processes.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/68248
Key Market Highlights
• Growing adoption of automated credit risk assessment tools
• Increasing focus on working capital and cash flow management
• Integration…
Session Border Controller Market Expands Rapidly as Enterprises and Telecom Oper …
The global session border controller (SBC) market is experiencing strong growth as telecom operators and enterprises increasingly deploy SBC solutions to secure, manage, and optimize real-time IP communications. SBCs play a critical role in protecting voice over IP (VoIP), unified communications (UC), and multimedia sessions from cyber threats while ensuring interoperability and quality of service.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/68246
Key Market Highlights
• Growing adoption of VoIP and…
Biofuel Market Including E-Methane and Sustainable Aviation Fuel Gains Strong Tr …
The global biofuel market, encompassing e-methane, sustainable aviation fuel (SAF), and other advanced biofuels, is witnessing robust growth as governments and industries intensify efforts to reduce carbon emissions and transition toward cleaner energy sources. These fuels play a critical role in achieving net-zero targets while enabling decarbonization of hard-to-abate sectors such as aviation, shipping, and heavy transportation.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/68244
Key Market Highlights
• Rapid growth of…
More Releases for Companion
Companion Animal Medicine Market Healthy Companions, Healthy Profits: Trends in …
Companion Animal Medicine Market to reach over USD 41.71 billion by the year 2031 - Exclusive Report by InsightAce Analytic
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Companion Animal Medicine Market Size, Share & Trends Analysis Report By Animal Type (Dogs, Cats, And Horses), Product (Pharmaceuticals And Medicated Feed Additives), Distribution Channel (Veterinary Hospitals And Clinics), And Indication (Antibiotics and Parasiticides)- Market Outlook…
Companion Diagnostics Market - Companion Diagnostics Industry Size, Share, Analy …
Companion diagnostics are medical devices and tests that provide essential information for the safe and effective use of a corresponding drug or biological product. These diagnostics are critical in the field of personalized medicine, as they help identify patients who are most likely to benefit from a particular therapeutic product. The Global Companion Diagnostics Market was valued at US$ 5.59 Billion in 2022 and is projected to reach US$ 13.74…
Companion Animal Digital Technology Market
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Companion Animal Digital Technology Market By Type of Service (Telemedicine, Telehealth, Reminder Applications, Trackers, Wearables, and Platform Market Places) Trends, Industry Competition Analysis, COVID-19 Impact Analysis, Revenue and Forecast Till 2031." features detailed market analysis and an extensive study on the current trends, exploring its significant factors.
The Artificial Intelligence (AI) In Beauty and Cosmetics Market…
Companion Diagnostics Market - Transforming Patient Outcomes: Pioneering Compani …
Newark, New Castle, USA: The "Companion Diagnostics Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Companion Diagnostics Market: https://www.growthplusreports.com/report/companion-diagnostics-market/8673
This latest report researches the industry structure, sales, revenue,…
Companion Animal Vaccine – Improving The Health Of Companion Animals In A Cost …
The companion animal vaccines market is expected to witness significant growth during the forecast period due to launch of vaccines for companion animals. For instance, in December 2017, Zoetis Inc. announced the launch of Vanguard CIV H3N2/H3N8, the latest vaccine in the company’s canine influenza virus (CIV) portfolio. The new bivalent vaccine helps protect dogs against the two strains of the virus known to be circulating in the U.S.
Moreover, the…
Global Companion Diagnostics Market
The Global Companion Diagnostics (CDx) Market was valued at US$ 1,614.5 million in 2015 and is projected to expand at a CAGR of 12.0% during the forecast period (2016–2024), as highlighted in a new report published by Coherent Market Insights. Development of multiple biomarkers and targeted drug therapy is boosting research and development collaboration among the industry players. This is expected to improve the time to market for companion diagnostic (CDx) test…
